SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001943462-24-000005
Filing Date
2024-11-18
Accepted
2024-11-18 16:16:52
Documents
1
Period of Report
2024-11-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3109
  Complete submission text file 0001943462-24-000005.txt   4883
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 283 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 203-632-6341
Dellora Investments LP (Reporting) CIK: 0001943462 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 241471729